Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Baricitinib helps with early hair regrowth in people with alopecia areata.

FFA in young women is often missed, and no single treatment works best.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Fulvestrant at 10 mg/kg does not promote hair regrowth in dogs with alopecia X.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib may help regrow hair in alopecia areata patients.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Leflunomide and anthralin may effectively treat severe alopecia areata.

The treatment is safe and shows promise for metastatic breast cancer.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.